Effectiveness, safety, initial optimal dose, and optimal maintenance dose range of basal insulin regimens for type 2 diabetes: A systematic review with meta‐analysis
Journal of Diabetes · 2023
DOI: 10.1111/1753-0407.13381 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Journal of Diabetes, 2023. Verfasst von Yingying Luo und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Peking University People's Hospital, Beijing, 100044, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Hypoglycemia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sponsored by the Chinese Geriatric Endocrine Society.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims
To investigate the effectiveness, safety, optimal starting dose, optimal maintenance dose range, and target fasting plasma glucose of five basal insulins in insulin‐naïve patients with type 2 diabetes mellitus.
Methods
MEDLINE, EMBASE, Web of Science, and the Cochrane Library were searched from January 2000 to February 2022. The Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) guidelines were followed and the Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) approach was adopted. The registration ID is CRD42022319078 in PROSPERO.
Results
Among 11 163 citations retrieved, 35 publications met the planned criteria. From meta‐analyses and network meta‐analyses, we found that when injecting basal insulin regimens at bedtime, the optimal choice in order of most to least effective might be glargine U‐300 or degludec U‐100, glargine U‐100 or detemir, followed by neutral protamine hagedorn (NPH). Injecting glargine U‐100 in the morning may be more effective (ie, more patients archiving glycated hemoglobin < 7.0%) and lead to fewer hypoglycemic events than injecting it at bedtime. The optimal starting dose for the initiation of any basal insulins can be 0.10–0.20 U/kg/day. There is no eligible evidence to investigate the optimal maintenance dose for basal insulins.
Conclusions
The five basal insulins are effective for the target population. Glargine U‐300, degludec U‐100, glargine U‐100, and detemir lead to fewer hypoglycemic events than NPH without compromising glycemic control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, Peking University People's Hospital, Beijing, 100044, China.
- Nottingham Ningbo GRADE Centre, University of Nottingham Ningbo China, Ningbo, Zhejiang, 315100, China.
- Academic Unit of Lifespan and Population Health, School of Medicine, The University of Nottingham, Nottingham, NG7 2UH, UK.
- Tianjin Tiantian Biotechnology Co., Ltd., Tianjin, 300000, China.
- OrthoEvidence Inc., Burlington, Ontario, L7N 3H8, Canada.
- Department of Endocrinology, Singapore General Hospital, 169608, Singapore, Singapore.
ORCID-Profile: Yingying Luo, Jun Xia, Zhan Zhao, Yaping Chang, Yong Mong Bee, Khue Thy Nguyen, Soo Lim, Daisuke Yabe, Alice Pik Shan Kong, Siew Pheng Chan, Marisa Deodat, Chaicharn Deerochanawong, Ketut Suastika, Chenchen Xu, Liming Chen, Wei Chen, Xiaoying Li, Weigang Zhao, Xiaomei Yao, Linong Ji
Förderung
- Sponsored by the Chinese Geriatric Endocrine Society
Zitieren
APA
Luo, Y., Xia, J., Zhao, Z., Chang, Y., Bee, Y. M., Nguyen, K. T., Lim, S., Yabe, D., McGill, M., Kong, A. P. S., Chan, S. P., Deodat, M., Deerochanawong, C., Suastika, K., Xu, C., Chen, L., Chen, W., Li, X., Zhao, W., …, & Ji, L. (2023). Effectiveness, safety, initial optimal dose, and optimal maintenance dose range of basal insulin regimens for type 2 diabetes: A systematic review with meta‐analysis. Journal of Diabetes. https://doi.org/10.1111/1753-0407.13381
Vancouver
Luo Y, Xia J, Zhao Z, Chang Y, Bee YM, Nguyen KT, et al. Effectiveness, safety, initial optimal dose, and optimal maintenance dose range of basal insulin regimens for type 2 diabetes: A systematic review with meta‐analysis. Journal of Diabetes. 2023. doi:10.1111/1753-0407.13381
BibTeX
@article{Luo2023,
author = {Luo, Yingying and Xia, Jun and Zhao, Zhan and Chang, Yaping and Bee, Yong Mong and Nguyen, Khue Thy and Lim, Soo and Yabe, Daisuke and McGill, Margaret and Kong, Alice Pik Shan and Chan, Siew Pheng and Deodat, Marisa and Deerochanawong, Chaicharn and Suastika, Ketut and Xu, Chenchen and Chen, Liming and Chen, Wei and Li, Xiaoying and Zhao, Weigang and Yao, Xiaomei and Ji, Linong},
title = {Effectiveness, safety, initial optimal dose, and optimal maintenance dose range of basal insulin regimens for type 2 diabetes: A systematic review with meta‐analysis},
journal = {Journal of Diabetes},
year = {2023},
doi = {10.1111/1753-0407.13381}
}
EUVIMED